Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan
2023-08-28 11:42
Specialised Therapeutics acquires commercialisation rights to new oral MND therapy
2023-08-28 04:00
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial
2023-08-25 20:58
Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA
2023-08-25 20:00
Tigermed Reports 2023 Interim Results
2023-08-25 18:39
Zhiyi Biotech Announced First Subject Dosed in the U.S. Phase 1 clinical Trial of SK10, in Development for Treatment of Chemotherapy-induced Diarrhea
2023-08-25 18:19
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics
2023-08-25 15:14
Laekna, Inc. (2105.HK) Announces Interim Results 2023
2023-08-25 08:00
Akeso Announced NDA Acceptance of IL-12/lL-23 Monoclonal Antibody Ebdarokimab for Moderate-to-severe Plaque Psoriasis by China NMPA
2023-08-24 20:00
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results
2023-08-24 14:00
PeptiGrowth Inc. and Orizuru Therapeutics, Inc. Enter into Joint Development of Novel Synthetic Peptide Based Growth Factor
2023-08-24 09:51
Samsung Biologics appoints new leadership to oversee quality and regulatory affairs
2023-08-24 07:59
Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023
2023-08-24 04:15
Dizal's Sunvozertinib Approved by China NMPA with Potential for Best-in-class Therapy in NSCLC with EGFR Exon20ins Mutations
2023-08-23 19:21
Aquedeon Medical, Inc. Receives FDA IDE Approval for the Duett Vascular Graft System
2023-08-23 18:00
Maypharm Launches the world first Adipose Stem Cell Exosome hair filler, HAIRNA Exosome Hair Fill
2023-08-23 17:00
ImmVira Appoints Howard L. Kaufman, M.D. as Consulting Medical Advisor
2023-08-23 10:51
Asieris Pharmaceuticals Unveils 2023 Semi-Annual Report, Demonstrating Initial Success of Specialty Pharma Strategy and Multi-Product Synergistic Commercialization
2023-08-22 20:58
Sanyou Biopharmaceuticals and Sinorda Biomedicine signed Strategic Cooperation Agreement for Advancing Innovative Drug Research and Development
2023-08-22 20:00
CARsgen Announced 2023 Interim Results
2023-08-22 19:30
1
64
65
66
67
68
431